Publication:
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial

Simple item page
dc.contributor.coauthorVigneswaran HT, Palsdottir T, Micoli C, Tilki D, Lin D, Cooperberg M, Eggener S, Falagario UG, Möller A, Aly M, Akre O, Wiklund P, Egevad L, Grönberg H, Nordström T, Eklund M.
dc.date.accessioned2025-12-31T08:24:31Z
dc.date.available2025-12-31
dc.date.issued2025
dc.description.fulltextYes
dc.description.harvestedfromManual
dc.description.indexedbyPubMed
dc.description.publisherscopeN/A
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.identifier.doi10.1016/j.eururo.2025.10.001
dc.identifier.embargoNo
dc.identifier.pubmed41107178
dc.identifier.quartileN/A
dc.identifier.urihttps://doi.org/10.1016/j.eururo.2025.10.001
dc.identifier.urihttps://hdl.handle.net/20.500.14288/31792
dc.language.isoN/A
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofEur Urol
dc.relation.openaccessYes
dc.rightsCC BY-NC-ND (Attribution-NonCommercial-NoDerivs)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleStockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial
dc.typeN/A
dspace.entity.typePublication

Files

Collections

Publications without Fulltext